-
ASSERTIO THERAPEUTICS, INC. et al v. ACTAVIS ELIZABETH LLC DC CAFC
- 2:15-cv-06797
- D.N.J.
- Judge: Claire C. Cecchi
+1
- Filed: 09/11/2015
- Closed: 04/11/2017
- Latest Docket Entry: 03/23/2020
- PACER
- Docket updated daily
2
Plaintiffs
3
Defendants
1
Accused
Product
1
Patent-in-Suit
1,357
Days in
Litigation
-
ASSERTIO THERAPEUTICS, INC. et al v. ACTAVIS ELIZABETH LLC DC CAFC
- 2:15-cv-06797
- D.N.J.
- Judge: Claire C. Cecchi
+1
- Filed: 09/11/2015
- Closed: 04/11/2017
- Latest Docket Entry: 03/23/2020
- PACER
- Docket updated daily
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 1 |
A method of treating polyneuropathic pain in a subject suffering therefrom, said method comprising administering to said subject an effective polyneuropathic pain inhibiting amount of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol or a
view more
|
Enforceable and Valid
Entry 110 Entry 90 |
| 2 |
A method according to claim 1, comprising administering a hydrochloride salt of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol.
|
Enforceable and Valid
Entry 110 Entry 90 |
| 3 |
A method according to claim 1, wherein said polyneuropathic pain is diabetic polyneuropathic pain.
|
Enforceable and Valid
Entry 110 Entry 90 |
| 6 |
A method of treating diabetic polyneuropathy in a subject suffering therefrom, said method comprising administering to said subject a pharmacologically effective amount of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol or a pharmaceutically
view more
|
Enforceable and Valid
Entry 110 Entry 90 |
-
Infringement
Actavis Elizabeth LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 250 mg dosages tapentadol hydrochloride extended release tablets50mg, 100mg, 150mg, 200mg, 250mg generic tapentadol hydrochloride extended release tabletsGeneric 50 mg, 100 mg, 200 mg | US 8,536,130 B2 |
1, 2, 3, 6
|
Infringement
Entry 110Entry 90 |
Actavis Ut
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 50mg, 100mg, 150mg, 200mg, 250mg generic tapentadol hydrochloride extended release tablets | US 8,536,130 B2 |
1, 2, 3, 6
|
Infringement
Entry 110
|
